Autoantibodies to Ca2+ binding protein Calnuc is a potential marker in colon cancer detection

Yao Chen, Ping Lin, Suimin Qiu, Xuan Xian Peng, Koksun Looi, Marilyn Gist Farquhar, Jian Ying Zhang

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Calnuc is a calcium (Ca2+) binding protein found in both Golgi and cytoplasm, and it may play a role in G protein-and Ca2+-regulated signal transduction events. This study was designed to investigate the possibility of whether Calnuc protein might be a tumor-associated antigen (TAA) that induces autoantibody response in human cancers, and to evaluate the feasibility of the Calnuc antigen-antibody system as a marker in cancer detection. Purified full-length recombinant Calnuc protein was used as an antigen in enzyme-linked immunoassay and Western blotting for the detection of autoantibodies in cancers. Sera from 447 patients with 9 different types of cancer were analyzed. Although the frequency of autoantibody to Calnuc was found to be 4.7% in total groups of cancer, it was not significantly different to that of normal individuals (1.2%). However, the frequency of autoantibody to Calnuc in colon cancer (11.5%) was significantly higher than that in normal individuals (1.2%). The expression analysis of Calnuc in multiple colon cancer tissues by immunohistochemistry on tissue array further confirmed the high specificity of Calnuc in colon cancer. Of 69 colon cancer tissue specimens examined, 41 tissues (59.4%) overexpressed Calnuc, while normal colon tissues did not show any expression of Calnuc. The subcellular distribution analysis of Calnuc examined by subcellular fractionation and immunofluorescence indicates that Calnuc is a membrane associated protein and mostly distributed in Golgi, which is consistent with previous reports. With adding Calnuc into a TAA array (including p53, c-myc, cyclin B1, cyclin D1), the cumulative frequency of antibody to multiple TAAs in colon cancer was raised to 65.4% which is significantly higher than the cumulative frequency in normal individuals (6.1%). This indicates that a mini-array of multiple TAAs which includes Calnuc might provide a novel non-invasive approach to enhance antibody detection for colon cancer diagnosis.

Original languageEnglish (US)
Pages (from-to)1137-1144
Number of pages8
JournalInternational Journal of Oncology
Volume30
Issue number5
StatePublished - May 2007

Fingerprint

Autoantibodies
Colonic Neoplasms
Carrier Proteins
Neoplasm Antigens
Neoplasms
Antibodies
Cyclin B1
Antigens
Calcium-Binding Proteins
Cyclin D1
Immunoenzyme Techniques
GTP-Binding Proteins
Recombinant Proteins
Fluorescent Antibody Technique
Signal Transduction
Membrane Proteins
Colon
Cytoplasm
Western Blotting
Immunohistochemistry

Keywords

  • Autoantibody
  • Calnuc
  • Cancer detection
  • Colon cancer
  • Tumor-associated antigen

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Chen, Y., Lin, P., Qiu, S., Peng, X. X., Looi, K., Farquhar, M. G., & Zhang, J. Y. (2007). Autoantibodies to Ca2+ binding protein Calnuc is a potential marker in colon cancer detection. International Journal of Oncology, 30(5), 1137-1144.

Autoantibodies to Ca2+ binding protein Calnuc is a potential marker in colon cancer detection. / Chen, Yao; Lin, Ping; Qiu, Suimin; Peng, Xuan Xian; Looi, Koksun; Farquhar, Marilyn Gist; Zhang, Jian Ying.

In: International Journal of Oncology, Vol. 30, No. 5, 05.2007, p. 1137-1144.

Research output: Contribution to journalArticle

Chen, Y, Lin, P, Qiu, S, Peng, XX, Looi, K, Farquhar, MG & Zhang, JY 2007, 'Autoantibodies to Ca2+ binding protein Calnuc is a potential marker in colon cancer detection', International Journal of Oncology, vol. 30, no. 5, pp. 1137-1144.
Chen, Yao ; Lin, Ping ; Qiu, Suimin ; Peng, Xuan Xian ; Looi, Koksun ; Farquhar, Marilyn Gist ; Zhang, Jian Ying. / Autoantibodies to Ca2+ binding protein Calnuc is a potential marker in colon cancer detection. In: International Journal of Oncology. 2007 ; Vol. 30, No. 5. pp. 1137-1144.
@article{899713c8115f4b38a99c89cdbc52f237,
title = "Autoantibodies to Ca2+ binding protein Calnuc is a potential marker in colon cancer detection",
abstract = "Calnuc is a calcium (Ca2+) binding protein found in both Golgi and cytoplasm, and it may play a role in G protein-and Ca2+-regulated signal transduction events. This study was designed to investigate the possibility of whether Calnuc protein might be a tumor-associated antigen (TAA) that induces autoantibody response in human cancers, and to evaluate the feasibility of the Calnuc antigen-antibody system as a marker in cancer detection. Purified full-length recombinant Calnuc protein was used as an antigen in enzyme-linked immunoassay and Western blotting for the detection of autoantibodies in cancers. Sera from 447 patients with 9 different types of cancer were analyzed. Although the frequency of autoantibody to Calnuc was found to be 4.7{\%} in total groups of cancer, it was not significantly different to that of normal individuals (1.2{\%}). However, the frequency of autoantibody to Calnuc in colon cancer (11.5{\%}) was significantly higher than that in normal individuals (1.2{\%}). The expression analysis of Calnuc in multiple colon cancer tissues by immunohistochemistry on tissue array further confirmed the high specificity of Calnuc in colon cancer. Of 69 colon cancer tissue specimens examined, 41 tissues (59.4{\%}) overexpressed Calnuc, while normal colon tissues did not show any expression of Calnuc. The subcellular distribution analysis of Calnuc examined by subcellular fractionation and immunofluorescence indicates that Calnuc is a membrane associated protein and mostly distributed in Golgi, which is consistent with previous reports. With adding Calnuc into a TAA array (including p53, c-myc, cyclin B1, cyclin D1), the cumulative frequency of antibody to multiple TAAs in colon cancer was raised to 65.4{\%} which is significantly higher than the cumulative frequency in normal individuals (6.1{\%}). This indicates that a mini-array of multiple TAAs which includes Calnuc might provide a novel non-invasive approach to enhance antibody detection for colon cancer diagnosis.",
keywords = "Autoantibody, Calnuc, Cancer detection, Colon cancer, Tumor-associated antigen",
author = "Yao Chen and Ping Lin and Suimin Qiu and Peng, {Xuan Xian} and Koksun Looi and Farquhar, {Marilyn Gist} and Zhang, {Jian Ying}",
year = "2007",
month = "5",
language = "English (US)",
volume = "30",
pages = "1137--1144",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - Autoantibodies to Ca2+ binding protein Calnuc is a potential marker in colon cancer detection

AU - Chen, Yao

AU - Lin, Ping

AU - Qiu, Suimin

AU - Peng, Xuan Xian

AU - Looi, Koksun

AU - Farquhar, Marilyn Gist

AU - Zhang, Jian Ying

PY - 2007/5

Y1 - 2007/5

N2 - Calnuc is a calcium (Ca2+) binding protein found in both Golgi and cytoplasm, and it may play a role in G protein-and Ca2+-regulated signal transduction events. This study was designed to investigate the possibility of whether Calnuc protein might be a tumor-associated antigen (TAA) that induces autoantibody response in human cancers, and to evaluate the feasibility of the Calnuc antigen-antibody system as a marker in cancer detection. Purified full-length recombinant Calnuc protein was used as an antigen in enzyme-linked immunoassay and Western blotting for the detection of autoantibodies in cancers. Sera from 447 patients with 9 different types of cancer were analyzed. Although the frequency of autoantibody to Calnuc was found to be 4.7% in total groups of cancer, it was not significantly different to that of normal individuals (1.2%). However, the frequency of autoantibody to Calnuc in colon cancer (11.5%) was significantly higher than that in normal individuals (1.2%). The expression analysis of Calnuc in multiple colon cancer tissues by immunohistochemistry on tissue array further confirmed the high specificity of Calnuc in colon cancer. Of 69 colon cancer tissue specimens examined, 41 tissues (59.4%) overexpressed Calnuc, while normal colon tissues did not show any expression of Calnuc. The subcellular distribution analysis of Calnuc examined by subcellular fractionation and immunofluorescence indicates that Calnuc is a membrane associated protein and mostly distributed in Golgi, which is consistent with previous reports. With adding Calnuc into a TAA array (including p53, c-myc, cyclin B1, cyclin D1), the cumulative frequency of antibody to multiple TAAs in colon cancer was raised to 65.4% which is significantly higher than the cumulative frequency in normal individuals (6.1%). This indicates that a mini-array of multiple TAAs which includes Calnuc might provide a novel non-invasive approach to enhance antibody detection for colon cancer diagnosis.

AB - Calnuc is a calcium (Ca2+) binding protein found in both Golgi and cytoplasm, and it may play a role in G protein-and Ca2+-regulated signal transduction events. This study was designed to investigate the possibility of whether Calnuc protein might be a tumor-associated antigen (TAA) that induces autoantibody response in human cancers, and to evaluate the feasibility of the Calnuc antigen-antibody system as a marker in cancer detection. Purified full-length recombinant Calnuc protein was used as an antigen in enzyme-linked immunoassay and Western blotting for the detection of autoantibodies in cancers. Sera from 447 patients with 9 different types of cancer were analyzed. Although the frequency of autoantibody to Calnuc was found to be 4.7% in total groups of cancer, it was not significantly different to that of normal individuals (1.2%). However, the frequency of autoantibody to Calnuc in colon cancer (11.5%) was significantly higher than that in normal individuals (1.2%). The expression analysis of Calnuc in multiple colon cancer tissues by immunohistochemistry on tissue array further confirmed the high specificity of Calnuc in colon cancer. Of 69 colon cancer tissue specimens examined, 41 tissues (59.4%) overexpressed Calnuc, while normal colon tissues did not show any expression of Calnuc. The subcellular distribution analysis of Calnuc examined by subcellular fractionation and immunofluorescence indicates that Calnuc is a membrane associated protein and mostly distributed in Golgi, which is consistent with previous reports. With adding Calnuc into a TAA array (including p53, c-myc, cyclin B1, cyclin D1), the cumulative frequency of antibody to multiple TAAs in colon cancer was raised to 65.4% which is significantly higher than the cumulative frequency in normal individuals (6.1%). This indicates that a mini-array of multiple TAAs which includes Calnuc might provide a novel non-invasive approach to enhance antibody detection for colon cancer diagnosis.

KW - Autoantibody

KW - Calnuc

KW - Cancer detection

KW - Colon cancer

KW - Tumor-associated antigen

UR - http://www.scopus.com/inward/record.url?scp=34447308559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447308559&partnerID=8YFLogxK

M3 - Article

C2 - 17390015

AN - SCOPUS:34447308559

VL - 30

SP - 1137

EP - 1144

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 5

ER -